Tumor Necrosis Factor Receptor Blocking Activity [MoA] - N0000175451

Name: Table of NDC products with tumor necrosis factor receptor blocking activity
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000175451
Pharmacologic Name	Tumor Necrosis Factor Receptor Blocking Activity
Pharmacologic Uses	tumor necrosis factor (TNF) blocker
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Tumor Necrosis Factor Receptor Blocking Activity

The table contains 65 products whose active ingredient are classified under the same pharmacologic class Tumor Necrosis Factor Receptor Blocking Activity [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0006-4305	Renflexis	Non-Proprietary Name: Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Merck Sharp & Dohme Llc	ACTIVE
0069-0809	Inflectra	Non-Proprietary Name: Infliximab-dyyb	Injection, Powder, Lyophilized, For Solution	Intravenous	Pfizer Laboratories Div Pfizer Inc	ACTIVE
50090-6411	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6428	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6704	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6705	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6706	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50090-6707	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	A-s Medication Solutions	ACTIVE
50474-710	Cimzia	Non-Proprietary Name: Certolizumab Pegol	Injection, Solution	Subcutaneous	Ucb, Inc.	ACTIVE
55513-399	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-400	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-410	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-411	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-413	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-479	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-480	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-481	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-482	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Inc	ACTIVE
55513-670	Avsola	Non-Proprietary Name: Infliximab-axxq	Injection, Powder, Lyophilized, For Solution	Intravenous	Amgen Inc	ACTIVE
57894-030	Remicade	Non-Proprietary Name: Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
57894-070	Simponi	Non-Proprietary Name: Golimumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE
57894-071	Simponi	Non-Proprietary Name: Golimumab	Injection, Solution	Subcutaneous	Janssen Biotech, Inc.	ACTIVE
57894-160	Infliximab	Non-Proprietary Name: Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
57894-350	Simponi Aria	Non-Proprietary Name: Golimumab	Solution	Intravenous	Janssen Biotech, Inc.	ACTIVE
58406-010	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-021	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-032	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-044	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-055	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-435	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-445	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-455	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
58406-456	Enbrel	Non-Proprietary Name: Etanercept	Solution	Subcutaneous	Immunex Corporation	ACTIVE
61314-327	Adalimumab	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc.	ACTIVE
61314-454	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-473	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-476	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
61314-509	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Sandoz Inc	ACTIVE
65219-554	Idacio	Non-Proprietary Name: Adalimumab	Injection, Solution	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
65219-556	Idacio	Non-Proprietary Name: Adalimumab	Injection, Solution	Subcutaneous	Fresenius Kabi Usa, Llc	ACTIVE
70114-210	Yusimry	Non-Proprietary Name: Adalimumab-aqvh	Injection, Solution	Subcutaneous	Coherus Biosciences Inc	ACTIVE
70114-220	Yusimry	Non-Proprietary Name: Adalimumab-aqvh	Injection, Solution	Subcutaneous	Coherus Biosciences Inc	ACTIVE
72511-400	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72511-482	Amjevita	Non-Proprietary Name: Adalimumab-atto	Injection	Subcutaneous	Amgen Usa Inc.	ACTIVE
72606-022	Adalimumab	Non-Proprietary Name: Adalimumab-aaty	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-023	Yuflyma	Non-Proprietary Name: Adalimumab	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-024	Yuflyma	Non-Proprietary Name: Adalimumab	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-025	Zymfentra	Non-Proprietary Name: Infliximab-dyyb	Injection	Subcutaneous	Celltrion Usa Inc.	ACTIVE
72606-030	Yuflyma	Non-Proprietary Name: Adalimumab	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-040	Adalimumab	Non-Proprietary Name: Adalimumab-aaty	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-041	Adalimumab	Non-Proprietary Name: Adalimumab-aaty	Injection	Subcutaneous	Celltrion Usa, Inc.	ACTIVE
72606-047	Zymfentra	Non-Proprietary Name: Infliximab-dyyb	Injection	Subcutaneous	Celltrion Usa Inc.	ACTIVE
78206-162	Renflexis	Non-Proprietary Name: Infliximab	Injection, Powder, Lyophilized, For Solution	Intravenous	Organon Llc	ACTIVE
78206-183	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-184	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-185	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-186	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
78206-187	Hadlima	Non-Proprietary Name: Adalimumab-bwwd	Solution	Subcutaneous	Organon Llc	ACTIVE
83457-100	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-101	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-102	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-103	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-107	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-108	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE
83457-113	Hyrimoz	Non-Proprietary Name: Adalimumab-adaz	Injection, Solution	Subcutaneous	Cordavis Limited	ACTIVE